{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:26:57Z","timestamp":1790908017529,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2007,3,1]]},"DOI":"10.1038\/sj.gt.3302885","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T05:03:23Z","timestamp":1163653403000},"page":"533-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Respective roles of TNF-\u03b1 and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice"],"prefix":"10.1038","volume":"14","author":[{"given":"K","family":"Benihoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Esselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jullienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Salone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bob\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bonardelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Connault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Opolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Saggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Perricaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"BF3302885_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","volume":"10","author":"K Benihoud","year":"1999","unstructured":"Benihoud K, Yeh P, Perricaudet M . Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440\u2013447.","journal-title":"Curr Opin Biotechnol"},{"key":"BF3302885_CR2","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","volume":"81","author":"WC Russell","year":"2000","unstructured":"Russell WC . Update on adenovirus and its vectors. J Gen Virol 2000; 81: 2573\u20132604.","journal-title":"J Gen Virol"},{"key":"BF3302885_CR3","first-page":"454","volume":"3","author":"S Kochanek","year":"2001","unstructured":"Kochanek S, Schiedner G, Volpers C . High-capacity \u2018gutless\u2019 adenoviral vectors. Curr Opin Mol Ther 2001; 3: 454\u2013463.","journal-title":"Curr Opin Mol Ther"},{"key":"BF3302885_CR4","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1089\/hum.1995.6.12-1553","volume":"6","author":"RD McCoy","year":"1995","unstructured":"McCoy RD, Davidson BL, Roessler BJ, Huffnagle GB, Janich SL, Laing TJ et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum Gene Ther 1995; 6: 1553\u20131560.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.gt.3302036","volume":"10","author":"Q Liu","year":"2003","unstructured":"Liu Q, Muruve DA . Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 2003; 10: 935\u2013940.","journal-title":"Gene Ther"},{"key":"BF3302885_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/10430349950018364","volume":"10","author":"DA Muruve","year":"1999","unstructured":"Muruve DA, Barnes MJ, Stillman IE, Libermann TA . Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 1999; 10: 965\u2013976.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR7","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1128\/JVI.74.9.3941-3947.2000","volume":"74","author":"SL Borgland","year":"2000","unstructured":"Borgland SL, Bowen GP, Wong NC, Libermann TA, Muruve DA . Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. J Virol 2000; 74: 3941\u20133947.","journal-title":"J Virol"},{"key":"BF3302885_CR8","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","volume":"76","author":"LA Tibbles","year":"2002","unstructured":"Tibbles LA, Spurrell JC, Bowen GP, Liu Q, Lam M, Zaiss AK et al. Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol 2002; 76: 1559\u20131568.","journal-title":"J Virol"},{"key":"BF3302885_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/10430340252792503","volume":"13","author":"GP Bowen","year":"2002","unstructured":"Bowen GP, Borgland SL, Lam M, Libermann TA, Wong NC, Muruve DA . Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Hum Gene Ther 2002; 13: 367\u2013379.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR10","doi-asserted-by":"publisher","first-page":"11377","DOI":"10.1073\/pnas.95.19.11377","volume":"95","author":"T Kafri","year":"1998","unstructured":"Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I . Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci USA 1998; 95: 11377\u201311382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR11","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1128\/JVI.74.16.7678-7682.2000","volume":"74","author":"V Molinier-Frenkel","year":"2000","unstructured":"Molinier-Frenkel V, Gahery-Segard H, Mehtali M, Le Boulaire C, Ribault S, Boulanger P et al. Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 2000; 74: 7678\u20137682.","journal-title":"J Virol"},{"key":"BF3302885_CR12","first-page":"437","volume":"2","author":"RD McCoy","year":"1995","unstructured":"McCoy RD, Davidson BL, Roessler BJ, Huffnagle GB, Simon RH . Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector-induced inflammation. Gene Ther 1995; 2: 437\u2013442.","journal-title":"Gene Ther"},{"key":"BF3302885_CR13","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.4049\/jimmunol.174.11.7310","volume":"174","author":"DM Shayakhmetov","year":"2005","unstructured":"Shayakhmetov DM, Li ZY, Ni S, Lieber A . Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors. J Immunol 2005; 174: 7310\u20137319.","journal-title":"J Immunol"},{"key":"BF3302885_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nm0395-182b","volume":"1","author":"NG McElvaney","year":"1995","unstructured":"McElvaney NG, Crystal RG . IL-6 release and airway administration of human CFR cDNA adenovirus vector. Nat Med 1995; 1: 182\u2013184.","journal-title":"Nat Med"},{"key":"BF3302885_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/(SICI)1521-2254(200005\/06)2:3<194::AID-JGM102>3.0.CO;2-5","volume":"2","author":"K Benihoud","year":"2000","unstructured":"Benihoud K, Salone B, Esselin S, Opolon P, Poli V, Di Giovine M et al. The role of IL-6 in the inflammatory and humoral response to adenoviral vectors. J Gene Med 2000; 2: 194\u2013203.","journal-title":"J Gene Med"},{"key":"BF3302885_CR16","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","volume":"88","author":"HS Ginsberg","year":"1991","unstructured":"Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651\u20131655.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR17","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1089\/hum.1998.9.15-2207","volume":"9","author":"K Otake","year":"1998","unstructured":"Otake K, Ennist DL, Harrod K, Trapnell BC . Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses. Hum Gene Ther 1998; 9: 2207\u20132222.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/mthe.2001.0329","volume":"3","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Chirmule N, Gao GP, Qian R, Croyle M, Joshi B et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 2001; 3: 697\u2013707.","journal-title":"Mol Ther"},{"issue":"Suppl 1","key":"BF3302885_CR19","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1002\/jgm.495","volume":"6","author":"MS Horwitz","year":"2004","unstructured":"Horwitz MS . Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J Gene Med 2004; 6 (Suppl 1): S172\u2013S183.","journal-title":"J Gene Med"},{"key":"BF3302885_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/08830180490265556","volume":"23","author":"DL Lichtenstein","year":"2004","unstructured":"Lichtenstein DL, Toth K, Doronin K, Tollefson AE, Wold WS . Functions and mechanisms of action of the adenovirus E3 proteins. Int Rev Immunol 2004; 23: 75\u2013111.","journal-title":"Int Rev Immunol"},{"key":"BF3302885_CR21","doi-asserted-by":"publisher","first-page":"13113","DOI":"10.1128\/JVI.78.23.13113-13121.2004","volume":"78","author":"SP Fessler","year":"2004","unstructured":"Fessler SP, Chin YR, Horwitz MS . Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1. J Virol 2004; 78: 13113\u201313121.","journal-title":"J Virol"},{"key":"BF3302885_CR22","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1128\/JVI.72.12.9514-9525.1998","volume":"72","author":"K Benihoud","year":"1998","unstructured":"Benihoud K, Saggio I, Opolon P, Salone B, Amiot F, Connault E et al. Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha. J Virol 1998; 72: 9514\u20139525.","journal-title":"J Virol"},{"key":"BF3302885_CR23","doi-asserted-by":"publisher","first-page":"9814","DOI":"10.1073\/pnas.94.18.9814","volume":"94","author":"KB Elkon","year":"1997","unstructured":"Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA et al. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci USA 1997; 94: 9814\u20139819.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1073\/pnas.91.1.215","volume":"91","author":"J Kolls","year":"1994","unstructured":"Kolls J, Peppel K, Silva M, Beutler B . Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 1994; 91: 215\u2013219.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","volume":"13","author":"V Poli","year":"1994","unstructured":"Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1189\u20131196.","journal-title":"EMBO J"},{"key":"BF3302885_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1006\/mthe.2001.0318","volume":"3","author":"RS Sung","year":"2001","unstructured":"Sung RS, Qin L, Bromberg JS . TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol Ther 2001; 3: 757\u2013767.","journal-title":"Mol Ther"},{"key":"BF3302885_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.gt.3302347","volume":"12","author":"AN Varnavski","year":"2005","unstructured":"Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM . Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice. Gene Ther 2005; 12: 427\u2013436.","journal-title":"Gene Ther"},{"key":"BF3302885_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","volume":"1","author":"G Cichon","year":"1999","unstructured":"Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999; 1: 360\u2013371.","journal-title":"J Gene Med"},{"key":"BF3302885_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","volume":"15","author":"DA Muruve","year":"2004","unstructured":"Muruve DA . The innate immune response to adenovirus vectors. Hum Gene Ther 2004; 15: 1157\u20131166.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/mthe.2002.0658","volume":"6","author":"H Ben-Gary","year":"2002","unstructured":"Ben-Gary H, McKinney RL, Rosengart T, Lesser ML, Crystal RG . Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes. Mol Ther 2002; 6: 287\u2013297.","journal-title":"Mol Ther"},{"key":"BF3302885_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1089\/hum.1998.9.13-1875","volume":"9","author":"HG Zhang","year":"1998","unstructured":"Zhang HG, Zhou T, Yang P, Edwards III CK, Curiel DT, Mountz JD . Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum Gene Ther 1998; 9: 1875\u20131884.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR32","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1128\/JVI.73.6.5098-5109.1999","volume":"73","author":"Y Peng","year":"1999","unstructured":"Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E et al. Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung. J Virol 1999; 73: 5098\u20135109.","journal-title":"J Virol"},{"key":"BF3302885_CR33","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1089\/hum.1997.8.17-2019","volume":"8","author":"L Qin","year":"1997","unstructured":"Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS . Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997; 8: 2019\u20132029.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"M Feldmann","year":"2001","unstructured":"Feldmann M, Maini RN . Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163\u2013196.","journal-title":"Annu Rev Immunol"},{"key":"BF3302885_CR35","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.145.12.4185","volume":"145","author":"HF Starnes Jr","year":"1990","unstructured":"Starnes Jr HF, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS . Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol 1990; 145: 4185\u20134191.","journal-title":"J Immunol"},{"key":"BF3302885_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.immunol.21.090501.080131","volume":"22","author":"SD Rosen","year":"2004","unstructured":"Rosen SD . Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004; 22: 129\u2013156.","journal-title":"Annu Rev Immunol"},{"key":"BF3302885_CR37","doi-asserted-by":"publisher","first-page":"12162","DOI":"10.1073\/pnas.211423598","volume":"98","author":"JM Trevejo","year":"2001","unstructured":"Trevejo JM, Marino MW, Philpott N, Josien R, Richards EC, Elkon KB et al. TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 2001; 98: 12162\u201312167.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","volume":"128","author":"H Mitoma","year":"2005","unstructured":"Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005; 128: 376\u2013392.","journal-title":"Gastroenterology"},{"key":"BF3302885_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clim.2005.01.007","volume":"115","author":"C Shen","year":"2005","unstructured":"Shen C, Maerten P, Geboes K, Van Assche G, Rutgeerts P, Ceuppens JL . Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol 2005; 115: 250\u2013259.","journal-title":"Clin Immunol"},{"key":"BF3302885_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cyto.2004.06.008","volume":"28","author":"S Kirchner","year":"2004","unstructured":"Kirchner S, Holler E, Haffner S, Andreesen R, Eissner G . Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. Cytokine 2004; 28: 67\u201374.","journal-title":"Cytokine"},{"key":"BF3302885_CR41","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1084\/jem.177.6.1575","volume":"177","author":"G Aversa","year":"1993","unstructured":"Aversa G, Punnonen J, de Vries JE . The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med 1993; 177: 1575\u20131585.","journal-title":"J Exp Med"},{"key":"BF3302885_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1365-2249.2002.01982.x","volume":"130","author":"T Fujii","year":"2002","unstructured":"Fujii T, Okada M, Mimori T, Craft J . The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL\/Mp-Fas(lpr) mice. Clin Exp Immunol 2002; 130: 224\u2013232.","journal-title":"Clin Exp Immunol"},{"key":"BF3302885_CR43","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1073\/pnas.0308368101","volume":"101","author":"NJ Philpott","year":"2004","unstructured":"Philpott NJ, Nociari M, Elkon KB, Falck-Pedersen E . Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc Natl Acad Sci USA 2004; 101: 6200\u20136205.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/mthe.2000.0062","volume":"1","author":"VN Krasnykh","year":"2000","unstructured":"Krasnykh VN, Douglas JT, van Beusechem VW . Genetic targeting of adenoviral vectors. Mol Ther 2000; 1: 391\u2013405.","journal-title":"Mol Ther"},{"key":"BF3302885_CR45","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1089\/hum.2004.15.1034","volume":"15","author":"H Mizuguchi","year":"2004","unstructured":"Mizuguchi H, Hayakawa T . Targeted adenovirus vectors. Hum Gene Ther 2004; 15: 1034\u20131044.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1172\/JCI119203","volume":"99","author":"PL Tran","year":"1997","unstructured":"Tran PL, Weinbach J, Opolon P, Linares-Cruz G, Reynes JP, Gregoire A et al. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J Clin Invest 1997; 99: 608\u2013617.","journal-title":"J Clin Invest"},{"key":"BF3302885_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0014-5793(90)80287-S","volume":"267","author":"P Gilardi","year":"1990","unstructured":"Gilardi P, Courtney M, Pavirani A, Perricaudet M . Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector. FEBS Lett 1990; 267: 60\u201362.","journal-title":"FEBS Lett"},{"key":"BF3302885_CR48","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1073\/pnas.95.11.6367","volume":"95","author":"F Griscelli","year":"1998","unstructured":"Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 1998; 95: 6367\u20136372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302885_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","volume":"7","author":"FJ Fallaux","year":"1996","unstructured":"Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215\u2013222.","journal-title":"Hum Gene Ther"},{"key":"BF3302885_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-1759(85)90063-8","volume":"83","author":"JP Michalski","year":"1985","unstructured":"Michalski JP, McCombs CC, Sheth S, McCarthy M, deShazo R . A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J Immunol Methods 1985; 83: 101\u2013112.","journal-title":"J Immunol Methods"},{"key":"BF3302885_CR51","first-page":"861","volume":"142","author":"Y Ohmori","year":"1993","unstructured":"Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA . Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993; 142: 861\u2013870.","journal-title":"Am J Pathol"},{"key":"BF3302885_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jviromet.2003.08.012","volume":"114","author":"P Saulnier","year":"2003","unstructured":"Saulnier P, Vidaud M, Gautier E, Motte N, Bellet D, Escudier B et al. Development and validation of a real-time PCR assay for the detection and quantitation of p53 recombinant adenovirus in clinical samples from patients treated with Ad5CMV-p53 (INGN 201). J Virol Methods 2003; 114: 55\u201364.","journal-title":"J Virol Methods"}],"updated-by":[{"DOI":"10.1038\/sj.gt.3302909","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T00:00:00Z","timestamp":1173139200000}}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T14:50:51Z","timestamp":1683643851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3,1]]}},"alternative-id":["BF3302885"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302885","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1058811.510740","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]},"assertion":[{"value":"31 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}